| Jumlah Saham Beredar | 3,192,040 shares |
| Saham Orang Dalam | 598,527 shares |
| Kepemilikan oleh Orang Dalam | 18.75 % |
| Orang Dalam Sejati | 29 |
Skor Sentimen Orang Dalam
Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.
Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.
Frekuensi Pembaruan: Setiap Hari
Skor Sentimen Petugas
Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.
Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.
Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.
Frekuensi Pembaruan: Setiap Hari
Metrik Utama Orang Dalam
Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.
Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).
Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)
3 ( )
98 out of 11305Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).
Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)
0.831 %( )
103 out of 11224Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.
Grafik Perdagangan Orang Dalam
Grafik berikut menunjukkan Cellectar Biosciences, Inc. transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.
Daftar Orang Dalam dan Metrik Profitabilitas
Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.
See our leaderboard of most profitable insider traders.
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
|
AWM Investment Company, Inc.
10% Owner -
|
0 | 0 | |
| Paul L Berns Director - [D] | 117,371 | 7,042 | |
| Charles Thomas III Bernhardt | 0 | ||
| James V Caruso Chief Executive Officer, Director - [D] [O] | 11,638 | 11,638 | |
|
Bihua Chen
Director, 10% Owner -
[D]
|
1,060,000 | 70,667 | |
|
Cormorant Asset Management, LLC
10% Owner -
|
1,060,000 | 70,667 | |
|
Cormorant Global Healthcare GP, LLC
10% Owner -
|
1,060,000 | 70,667 | |
|
Cormorant Global Healthcare Master Fund, LP
10% Owner -
|
1,060,000 | 70,667 | |
| Frederick W Driscoll Director - [D] | 19,417 | 971 |
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
| Dov Elefant Chief Financial Officer - [O] | 11,755 | 588 | |
| Friend John E. II VP, Chief Medical Officer - [O] | 6,666 | 333 | |
| John Patrick Genn VP of Business Development - [O] | 7,064 | 471 | |
| Igor D Grachev | 80,000 | ||
| Stephen A Hill Director - [D] | 18,000 | 900 | |
| Hamill John P. | 0 | ||
| Richard Hertzberg - | 280,000 | 280,000 | |
| Chad J Kolean Chief Financial Officer - [O] | 6,418 | 6,418 | |
| Darrell Shane Lea Chief Commercial Officer - [O] | 39,599 | 1,320 | |
| Jarrod Longcor Chief Operating Officer - [O] | 12,768 | 12,768 |
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
| Stefan Loren | 50,000 | ||
|
Austin W & Greenhouse David M Marxe
10% Owner -
|
1,142,368 | 76,158 | |
| John Neis Director - [D] | 626,103 | 37,566 | |
| Brian M Posner | 30,000 | ||
| Simon Pedder President and CEO, Director - [D] [O] | 13,300 | 887 | |
| Andrei Shustov Senior Vice President, Medical - [O] | 55,038 | 1,835 | |
| Douglas J Swirsky Director - [D] | 25,000 | 1,250 | |
| Cameron Szakacs | 50,000 | ||
|
Alumni Research Foundation Wisconsin
10% Owner -
|
938,968 | 56,338 | |
| Jamey P Weichert Chief Scientific Officer, Director - [D] [O] | 470,672 | 31,378 |
Report errors via our new Insider Auditing Tool
Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di CLRB / Cellectar Biosciences, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek
Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di CLRB / Cellectar Biosciences, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Riwayat Transaksi
Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.
| Berkas Tanggal |
Perdagangan Tanggal |
Formulir | Orang Dalam | Ticker | Judul Keamanan | Kode | Langsung | Latihan Harga |
Satuan Harga |
Unit Diubah |
Nilai Diubah (1 ribu) |
Sisa Pilihan |
Sisa Saham |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-03 | 2025-07-02 | 4 | CARUSO JAMES V | CLRB | Common Stock | D | 4.9900 | 10,000 | 50 | 11,638 | ||||
| 2025-07-03 | 2025-07-02 | 4 | Longcor Jarrod | CLRB | Common Stock | D | 4.9900 | 10,000 | 50 | 12,768 | ||||
| 2025-07-03 | 2025-07-02 | 4 | Kolean Chad J | CLRB | Common Stock | D | 4.9900 | 5,000 | 25 | 6,418 | ||||
| 2025-03-12 | 2025-01-10 | 4 | Longcor Jarrod | CLRB | Common Stock | D | 0.2800 | 30,000 | 8 | 83,141 | ||||
| 2023-12-12 | 2023-12-08 | 4 | Lea Darrell Shane | CLRB | Common Stock | D | 39,599 | 39,599 | ||||||
| 2023-12-12 | 2023-12-08 | 4 | Kolean Chad J | CLRB | Common Stock | D | 42,554 | 42,578 | ||||||
| 2023-12-12 | 2023-12-08 | 4 | Shustov Andrei | CLRB | Common Stock | D | 47,856 | 55,038 | ||||||
| 2023-12-12 | 2023-12-08 | 4 | CARUSO JAMES V | CLRB | Common Stock | D | 40,596 | 49,236 | ||||||
| 2023-12-12 | 2023-12-08 | 4 | Longcor Jarrod | CLRB | Common Stock | D | 42,927 | 53,141 | ||||||
| 2023-03-16 | 3 | Shustov Andrei | CLRB | Common Stock | D | 7,182 | ||||||||
| 2022-04-15 | 3/A | Kolean Chad J | CLRB | Common Stock | D | 240 | ||||||||
| 2022-02-24 | 2022-02-22 | 4 | Kolean Chad J | CLRB | Stock option (right to buy) | D | 0.49 | 150,000 | 150,000 | |||||
| 2022-01-27 | 2022-01-25 | 4 | CARUSO JAMES V | CLRB | Stock option (right to buy) | D | 0.55 | 1,419,000 | 1,419,000 | |||||
| 2022-01-27 | 2022-01-25 | 4 | Elefant Dov | CLRB | Stock option (right to buy) | D | 0.55 | 422,000 | 422,000 | |||||
| 2022-01-27 | 2022-01-25 | 4 | Longcor Jarrod | CLRB | Stock option (right to buy) | D | 0.55 | 475,000 | 475,000 | |||||
| 2021-09-14 | 2021-09-14 | 4 | Swirsky Douglas J | CLRB | Common Stock | D | 1.0400 | 25,000 | 26 | 25,000 | ||||
| 2021-09-07 | 2021-09-03 | 4 | DRISCOLL FREDERICK W | CLRB | Common Stock | D | 1.0426 | 19,417 | 20 | 19,417 | ||||
| 2021-07-02 | 2021-06-30 | 4 | NEIS JOHN | CLRB | Stock option (right to buy) | D | 1.19 | 78,000 | 78,000 | |||||
| 2021-07-02 | 2021-06-30 | 4 | DRISCOLL FREDERICK W | CLRB | Stock option (right to buy) | D | 1.19 | 78,000 | 78,000 | |||||
| 2021-07-02 | 2021-06-30 | 4 | Swirsky Douglas J | CLRB | Stock option (right to buy) | D | 1.19 | 117,000 | 117,000 | |||||
| 2021-07-02 | 2021-06-30 | 4 | Loren Stefan | CLRB | Stock option (right to buy) | D | 1.19 | 78,000 | 78,000 | |||||
| 2021-07-02 | 2021-06-30 | 4 | Chanan-Khan Asher | CLRB | Stock option (right to buy) | D | 1.19 | 78,000 | 78,000 | |||||
| 2021-03-19 | 2021-03-18 | 4 | NEIS JOHN | CLRB | Series A Warrants | D | 30.40 | 0.2522 | -23,232 | -6 | 0 | |||
| 2021-03-19 | 2021-03-17 | 4 | NEIS JOHN | CLRB | Series A Warrants | D | 30.40 | 0.2775 | -58,640 | -16 | 23,232 | |||
| 2021-03-16 | 2021-03-16 | 4 | NEIS JOHN | CLRB | Series A Warrants | D | 30.40 | 0.3091 | -100,515 | -31 | 81,872 | |||
| 2021-03-16 | 2021-03-15 | 4 | NEIS JOHN | CLRB | Series A Warrants | D | 30.40 | 0.2652 | -11,200 | -3 | 182,387 | |||
| 2021-03-16 | 2021-03-12 | 4 | NEIS JOHN | CLRB | Series A Warrants | D | 30.40 | 0.2668 | -41,155 | -11 | 193,587 | |||
| 2021-03-05 | 2021-03-04 | 4 | Elefant Dov | CLRB | Stock option (right to buy) | D | 1.74 | 430,000 | 430,000 | |||||
| 2021-03-05 | 2021-03-04 | 4 | CARUSO JAMES V | CLRB | Series A Warrants | D | 30.40 | 0.1857 | 46,948 | 9 | 0 | |||
| 2021-03-05 | 2021-03-04 | 4 | CARUSO JAMES V | CLRB | Stock option (right to buy) | D | 1.74 | 1,600,000 | 1,600,000 | |||||
| 2021-03-05 | 2021-03-04 | 4 | CARUSO JAMES V | CLRB | Common Stock | D | 1.6978 | 5,100 | 9 | 86,401 | ||||
| 2021-03-05 | 2021-03-04 | 4 | Friend John E. II | CLRB | Stock option (right to buy) | D | 1.74 | 330,000 | 330,000 | |||||
| 2021-03-05 | 2021-03-04 | 4 | Longcor Jarrod | CLRB | Stock option (right to buy) | D | 1.74 | 450,000 | 450,000 | |||||
| 2020-12-28 | 2020-12-28 | 4 | Elefant Dov | CLRB | Common Stock | D | 1.3500 | 7,407 | 10 | 11,755 | ||||
| 2020-12-28 | 2020-12-28 | 4 | Longcor Jarrod | CLRB | Common Stock | D | 1.3500 | 29,630 | 40 | 102,148 | ||||
| 2020-12-28 | 2020-12-28 | 4 | CARUSO JAMES V | CLRB | Common Stock | D | 1.3500 | 37,037 | 50 | 81,301 | ||||
| 2020-07-06 | 3 | Friend John E. II | CLRB | Common Stock | D | 6,666 | ||||||||
| 2020-07-06 | 3 | Friend John E. II | CLRB | Common Stock | D | 6,666 | ||||||||
| 2020-07-06 | 3 | Friend John E. II | CLRB | Common Stock | D | 6,666 | ||||||||
| 2020-07-06 | 2020-07-01 | 4 | Friend John E. II | CLRB | Stock option (right to buy) | D | 1.34 | 100,000 | 100,000 | |||||
| 2020-06-25 | 2020-06-24 | 4 | HILL STEPHEN A | CLRB | Stock option (right to buy) | D | 1.28 | 50,000 | 50,000 | |||||
| 2020-06-25 | 2020-06-24 | 4 | NEIS JOHN | CLRB | Stock option (right to buy) | D | 1.28 | 50,000 | 50,000 | |||||
| 2020-06-25 | 2020-06-24 | 4 | Loren Stefan | CLRB | Stock option (right to buy) | D | 1.28 | 50,000 | 50,000 | |||||
| 2020-06-25 | 2020-06-24 | 4 | DRISCOLL FREDERICK W | CLRB | Stock option (right to buy) | D | 1.28 | 50,000 | 50,000 | |||||
| 2020-06-25 | 2020-06-24 | 4 | Swirsky Douglas J | CLRB | Stock option (right to buy) | D | 1.28 | 80,000 | 80,000 | |||||
| 2020-06-08 | 2020-06-04 | 4 | HILL STEPHEN A | CLRB | Common Stock | D | 1.0799 | 18,000 | 19 | 18,000 | ||||
| 2020-06-08 | 2020-06-05 | 4 | CARUSO JAMES V | CLRB | Series H Warrants | D | 1.21 | 0.0100 | 10,870 | 0 | 10,870 | |||
| 2020-06-08 | 2020-06-05 | 4 | CARUSO JAMES V | CLRB | Common Stock | D | 1.1450 | 21,740 | 25 | 44,264 | ||||
| 2020-06-08 | 2020-06-05 | 4 | Longcor Jarrod | CLRB | Series H Warrants | D | 1.21 | 0.0100 | 32,609 | 0 | 32,609 | |||
| 2020-06-08 | 2020-06-05 | 4 | Longcor Jarrod | CLRB | Common Stock | D | 1.1450 | 65,218 | 75 | 72,518 | ||||
| 2020-06-08 | 2020-06-05 | 4 | Elefant Dov | CLRB | Series H Warrants | D | 1.21 | 0.0100 | 2,174 | 0 | 2,174 | |||
| 2020-06-08 | 2020-06-05 | 4 | Elefant Dov | CLRB | Common Stock | D | 1.1450 | 4,348 | 5 | 4,348 | ||||
| 2020-03-05 | 2020-02-03 | 4/A | CARUSO JAMES V | CLRB | Stock option (right to buy) | D | 2.71 | 100,000 | 100,000 | |||||
| 2020-03-05 | 2020-02-03 | 4/A | Longcor Jarrod | CLRB | Stock option (right to buy) | D | 2.71 | 40,000 | 40,000 | |||||
| 2020-03-05 | 2020-02-03 | 4/A | Elefant Dov | CLRB | Stock Option (right to buy) | D | 2.71 | 10,000 | 10,000 | |||||
| 2020-02-04 | 2020-02-03 | 4 | CARUSO JAMES V | CLRB | Common stock | D | 2.7100 | 100,000 | 271 | 100,000 | ||||
| 2020-02-04 | 2020-02-03 | 4 | Longcor Jarrod | CLRB | Common stock | D | 2.7100 | 40,000 | 108 | 40,000 | ||||
| 2020-02-04 | 2020-02-03 | 4 | Elefant Dov | CLRB | Common stock | D | 2.7100 | 10,000 | 27 | 10,000 | ||||
| 2020-01-08 | 2020-01-06 | 4 | Grachev Igor D | CLRB | Stock Option (right to buy) | D | 2.46 | 80,000 | 80,000 | |||||
| 2019-09-11 | 2019-09-10 | 4 | Elefant Dov | CLRB | Stock Option (right to buy) | D | 2.32 | 90,000 | 90,000 | |||||
| 2019-06-14 | 2019-06-13 | 4 | NEIS JOHN | CLRB | Stock option (right to buy) | D | 2.15 | 6,500 | 6,500 | |||||
| 2019-06-14 | 2019-06-13 | 4 | Swirsky Douglas J | CLRB | Stock option (right to buy) | D | 2.15 | 9,750 | 9,750 | |||||
| 2019-06-14 | 2019-06-13 | 4 | DRISCOLL FREDERICK W | CLRB | Stock option (right to buy) | D | 2.15 | 6,500 | 6,500 | |||||
| 2019-06-14 | 2019-06-13 | 4 | Loren Stefan | CLRB | Stock option (right to buy) | D | 2.15 | 6,500 | 6,500 | |||||
| 2019-06-14 | 2019-06-13 | 4 | HILL STEPHEN A | CLRB | Stock option (right to buy) | D | 2.15 | 6,500 | 6,500 | |||||
| 2019-03-01 | 2019-02-28 | 4 | Longcor Jarrod | CLRB | Common Stock | D | 2.0025 | 100 | 0 | 7,300 | ||||
| 2019-01-18 | 2019-01-17 | 4 | CARUSO JAMES V | CLRB | Stock option (right to buy) | D | 1.99 | 75,000 | 75,000 | |||||
| 2019-01-18 | 2019-01-17 | 4 | POSNER BRIAN M | CLRB | Stock option (right to buy) | D | 1.99 | 30,000 | 30,000 | |||||
| 2019-01-18 | 2019-01-17 | 4 | Longcor Jarrod | CLRB | Stock option (right to buy) | D | 1.99 | 30,000 | 30,000 | |||||
| 2018-11-30 | 2018-11-30 | 4 | CARUSO JAMES V | CLRB | Common Stock, par value $0.00001 per share | D | 2.2820 | 1,000 | 2 | 22,354 | ||||
| 2018-11-30 | 2018-11-29 | 4 | HILL STEPHEN A | CLRB | Warrants | D | 468.00 | 0.0510 | 530 | 0 | 0 | |||
| 2018-11-30 | 2018-11-29 | 4 | HILL STEPHEN A | CLRB | Series A Warrants | D | 30.40 | 0.0977 | 9,390 | 1 | 0 | |||
| 2018-11-30 | 2018-11-29 | 4 | HILL STEPHEN A | CLRB | Common Stock | D | 2.2100 | -53 | -0 | 0 | ||||
| 2018-11-30 | 2018-11-29 | 4 | HILL STEPHEN A | CLRB | Common Stock | D | 2.2101 | -939 | -2 | 53 | ||||
| 2018-10-15 | 2018-10-12 | 4 | DRISCOLL FREDERICK W | CLRB | Stock option (right to buy) | D | 2.61 | 13,000 | 13,000 | |||||
| 2018-10-15 | 2018-10-12 | 4 | HILL STEPHEN A | CLRB | Stock option (right to buy) | D | 2.61 | 13,000 | 13,000 | |||||
| 2018-10-15 | 2018-10-12 | 4 | Loren Stefan | CLRB | Stock option (right to buy) | D | 2.61 | 13,000 | 13,000 | |||||
| 2018-10-15 | 2018-10-12 | 4 | NEIS JOHN | CLRB | Stock option (right to buy) | D | 2.61 | 13,000 | 13,000 | |||||
| 2018-10-15 | 2018-10-12 | 4 | CARUSO JAMES V | CLRB | Stock option (right to buy) | D | 2.61 | 150,000 | 150,000 | |||||
| 2018-10-15 | 2018-10-12 | 4 | Longcor Jarrod | CLRB | Stock option (right to buy) | D | 2.61 | 63,000 | 63,000 | |||||
| 2018-10-15 | 2018-10-12 | 4 | Friend John E. II | CLRB | Stock option (right to buy) | D | 2.61 | 63,000 | 63,000 | |||||
| 2018-10-15 | 2018-10-12 | 4 | POSNER BRIAN M | CLRB | Stock option (right to buy) | D | 2.61 | 54,000 | 54,000 | |||||
| 2018-10-15 | 2018-10-12 | 4 | Swirsky Douglas J | CLRB | Stock option (right to buy) | D | 2.61 | 19,500 | 19,500 | |||||
| 2018-08-17 | 2018-08-16 | 4 | Longcor Jarrod | CLRB | Common Stock | D | 2.7100 | 500 | 1 | 7,200 | ||||
| 2018-04-06 | 2018-04-06 | 4 | POSNER BRIAN M | CLRB | Stock option (right to buy) | D | 1.17 | 80,000 | 80,000 | |||||
| 2018-03-14 | 2018-03-12 | 4 | CARUSO JAMES V | CLRB | Common Stock | D | 1.1972 | -34,000 | -41 | 213,548 | ||||
| 2018-03-14 | 2018-03-13 | 4 | Longcor Jarrod | CLRB | Common Stock | D | 1.1844 | -13,000 | -15 | 67,000 | ||||
| 2017-11-16 | 2017-11-14 | 4 | NEIS JOHN | CLRB | Common Stock, par value $0.00001 per share | I | 1.4942 | -5,214 | -8 | 626,103 | ||||
| 2017-09-25 | 2017-09-18 | 4 | Longcor Jarrod | CLRB | Employee Stock Option (right to buy) | D | 1.83 | 25,000 | 25,000 | |||||
| 2017-06-01 | 2017-05-31 | 4 | Loren Stefan | CLRB | Stock option (right to buy) | D | 1.74 | 10,000 | 10,000 | |||||
| 2017-06-01 | 2017-05-31 | 4 | NEIS JOHN | CLRB | Stock option (right to buy) | D | 1.74 | 10,000 | 10,000 | |||||
| 2017-06-01 | 2017-05-31 | 4 | DRISCOLL FREDERICK W | CLRB | Stock option (right to buy) | D | 1.74 | 10,000 | 10,000 | |||||
| 2017-06-01 | 2017-05-31 | 4 | HILL STEPHEN A | CLRB | Stock option (right to buy) | D | 1.74 | 10,000 | 10,000 | |||||
| 2017-06-01 | 2017-05-31 | 4 | Swirsky Douglas J | CLRB | Stock option (right to buy) | D | 1.74 | 10,000 | 10,000 | |||||
| 2017-04-20 | 2017-04-18 | 4 | CARUSO JAMES V | CLRB | Common stock | D | 200,000 | 247,548 | ||||||
| 2017-04-20 | 2017-04-18 | 4 | Longcor Jarrod | CLRB | Common stock | D | 80,000 | 80,000 | ||||||
| 2017-04-20 | 2017-04-18 | 4 | Kolean Chad J | CLRB | Common stock | D | 80,000 | 80,000 | ||||||
| 2017-04-18 | 2017-04-17 | 4 | Friend John E. II | CLRB | Common stock | D | 100,000 | 100,000 | ||||||
| 2016-11-30 | 2016-11-29 | 4 | NEIS JOHN | CLRB | Series C Warrants (right to buy) | I | 1.50 | 0.0100 | 333,333 | 3 | 607,946 | |||
| 2016-11-30 | 2016-11-29 | 4 | NEIS JOHN | CLRB | Common Stock, par value $0.00001 per share | I | 1.4900 | 333,333 | 497 | 631,317 | ||||
| 2016-11-01 | 2016-10-31 | 4 | Hertzberg Richard | clrB | Cellectar Biosciences, Inc. common stock (CLRB) | D | 2.0290 | -21,000 | -43 | 280,000 | ||||
| 2016-11-01 | 2016-08-09 | 4 | Hertzberg Richard | clrB | Cellectar Biosciences Inc. Warrant (CLRBW) | D | 46.80 | 1.7500 | -40,916 | -72 | 0 | |||
| 2016-08-12 | 2016-07-15 | 4 | Longcor Jarrod | CLRB | Employee Stock Option (right to buy) | D | 2.93 | 75,000 | 75,000 | |||||
| 2016-07-07 | 2016-07-05 | 4 | Loren Stefan | CLRB | Stock option (right to buy) | D | 3.34 | 0.0100 | 22,500 | 0 | 23,500 | |||
| 2016-07-06 | 2016-07-05 | 4 | NEIS JOHN | CLRB | Stock option (right to buy) | D | 3.34 | 0.0100 | 22,500 | 0 | 24,750 | |||
| 2016-07-06 | 2016-07-05 | 4 | HILL STEPHEN A | CLRB | Stock option (right to buy) | D | 3.34 | 0.0100 | 22,500 | 0 | 25,434 | |||
| 2016-06-14 | 2015-12-28 | 5 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. (CLRB) Common Stock | D | 0.7200 | 75,000 | 54 | 75,000 | ||||
| 2016-06-14 | 2015-12-24 | 5 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. (CLRB) Common Stock | D | 0.7900 | 50,000 | 40 | 50,000 | ||||
| 2016-06-14 | 2015-12-22 | 5 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. (CLRB) Common Stock | D | 0.9100 | 5,000 | 5 | 5,000 | ||||
| 2016-06-14 | 2015-12-16 | 5 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. (CLRB) Common Stock | D | 0.9100 | 19,592 | 18 | 19,592 | ||||
| 2016-06-14 | 2015-12-11 | 5 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. (CLRB) Common Stock | D | 0.9240 | 16,250 | 15 | 16,250 | ||||
| 2016-06-14 | 2015-12-08 | 5 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. (CLRB) Common Stock | D | 0.9225 | 10,000 | 9 | 10,000 | ||||
| 2016-06-14 | 2014-10-03 | 5 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. (CLRB) Common Stock | D | 2.2500 | 10,000 | 22 | 10,000 | ||||
| 2016-06-14 | 2014-09-19 | 5 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. (CLRB) Common Stock | D | 2.6700 | 20,000 | 53 | 20,000 | ||||
| 2016-06-14 | 2014-08-20 | 5 | Hertzberg Richard | CLRB | Cellectar Biosciences Inc. Warrant (CLRBW) | D | 4.68 | 0.0100 | 409,158 | 4 | 409,158 | |||
| 2016-06-14 | 2014-08-20 | 5 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. (CLRB) Common Stock | D | 3.7500 | 409,158 | 1,534 | 409,158 | ||||
| 2016-06-14 | 2011-12-11 | 5 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. Warrant 12/5/2011 | D | 12.00 | 0.0002 | 10,000 | 0 | 10,000 | |||
| 2016-06-14 | 2011-12-05 | 5 | Hertzberg Richard | CLRB | Novelos Therapeutics, Inc. New (NVLT) | D | 12.0000 | 10,000 | 120 | 10,000 | ||||
| 2016-06-14 | 2016-04-21 | 4 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. | D | 1.9000 | 3,758 | 7 | 301,000 | ||||
| 2016-06-14 | 2016-04-15 | 4 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. Series A Warrant (CLRBZ) | D | 3.04 | 0.0100 | 234,742 | 2 | 41,915 | |||
| 2016-06-14 | 2016-04-15 | 4 | Hertzberg Richard | CLRB | Cellectar Biosciences, Inc. (CLRB) Common Stock | D | 2.1200 | 234,742 | 498 | 297,242 | ||||
| 2016-05-23 | 2016-05-12 | 4 | CARUSO JAMES V | CLRB | Stock option (right to buy) | D | 1.48 | 0.0100 | 200,000 | 2 | 237,500 | |||
| 2016-05-23 | 2016-05-12 | 4 | Kolean Chad J | CLRB | Stock option (right to buy) | D | 1.48 | 0.0100 | 50,000 | 0 | 52,000 | |||
| 2016-05-23 | 2016-05-12 | 4 | Weichert Jamey P | CLRB | Stock option (right to buy) | D | 1.48 | 0.0100 | 40,000 | 0 | 42,895 | |||
| 2016-04-25 | 3 | WISCONSIN ALUMNI RESEARCH FOUNDATION | CLRB | Common Stock | D | 938,968 | ||||||||
| 2016-04-25 | 3 | WISCONSIN ALUMNI RESEARCH FOUNDATION | CLRB | Common Stock | D | 938,968 | ||||||||
| 2016-04-21 | 2016-04-20 | 4 | CARUSO JAMES V | CLRB | Series A Warrants | D | 3.04 | 0.0100 | 46,948 | 0 | 46,948 | |||
| 2016-04-21 | 2016-04-20 | 4 | CARUSO JAMES V | CLRB | Common Stock, par value $0.00001 per share | D | 2.1200 | 46,948 | 100 | 47,548 | ||||
| 2016-04-21 | 2016-04-20 | 4 | BERNS PAUL L | CLRB | Series A Warrants | D | 3.04 | 0.0100 | 117,371 | 1 | 117,371 | |||
| 2016-04-21 | 2016-04-20 | 4 | BERNS PAUL L | CLRB | Common Stock, par value $0.00001 per share | D | 2.1200 | 117,371 | 249 | 117,371 | ||||
| 2016-04-21 | 2016-04-20 | 4 | NEIS JOHN | CLRB | Series A Warrants | I | 3.04 | 0.0100 | 234,742 | 2 | 274,613 | |||
| 2016-04-21 | 2016-04-20 | 4 | NEIS JOHN | CLRB | Common Stock, par value $0.00001 per share | I | 2.1200 | 234,742 | 498 | 297,984 | ||||
| 2016-04-21 | 2016-04-20 | 4 | HILL STEPHEN A | CLRB | Series A Warrants | D | 3.04 | 0.0100 | 9,390 | 0 | 9,920 | |||
| 2016-04-21 | 2016-04-20 | 4 | HILL STEPHEN A | CLRB | Common Stock, par value $0.00001 per share | D | 2.1200 | 9,390 | 20 | 9,920 | ||||
| 2016-01-04 | 2015-12-31 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 0.6955 | -35,253 | -25 | 0 | ||||
| 2016-01-04 | 2015-12-30 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 0.6873 | -64,747 | -45 | 35,253 | ||||
| 2015-12-30 | 2015-12-29 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 0.6929 | -82,847 | -57 | 100,000 | ||||
| 2015-12-29 | 2015-12-28 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 0.6903 | -150,975 | -104 | 182,847 | ||||
| 2015-12-29 | 2015-12-24 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 0.7596 | -216,991 | -165 | 333,822 | ||||
| 2015-12-23 | 2015-12-22 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 0.9046 | -7,938 | -7 | 550,813 | ||||
| 2015-12-22 | 2015-12-21 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 0.9223 | -20,621 | -19 | 558,751 | ||||
| 2015-12-22 | 2015-12-18 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 0.8988 | -7,000 | -6 | 579,372 | ||||
| 2015-12-18 | 2015-12-17 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 0.8816 | -18,240 | -16 | 586,372 | ||||
| 2015-12-18 | 2015-12-16 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 0.8644 | -52,985 | -46 | 604,612 | ||||
| 2015-12-16 | 2015-12-15 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 0.8243 | -44,965 | -37 | 657,597 | ||||
| 2015-12-08 | 2015-12-04 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 1.0619 | -49,950 | -53 | 702,562 | ||||
| 2015-12-08 | 2015-12-04 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 1.1400 | -1,000 | -1 | 752,512 | ||||
| 2015-12-03 | 2015-12-01 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 1.0405 | -42,110 | -44 | 753,512 | ||||
| 2015-12-01 | 2015-11-25 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 1.2026 | -4,378 | -5 | 795,622 | ||||
| 2015-11-25 | 2015-11-24 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 1.2747 | -67,102 | -86 | 800,000 | ||||
| 2015-11-25 | 2015-11-23 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 1.2110 | -106,700 | -129 | 867,102 | ||||
| 2015-11-25 | 2015-11-24 | 4 | CARUSO JAMES V | CLRB | Common Stock, par value $0.00001 per share | D | 1.3020 | 1,000 | 1 | 6,000 | ||||
| 2015-11-24 | 2015-11-20 | 4 | CARUSO JAMES V | CLRB | Common Stock, par value $0.00001 per share | D | 1.1593 | 1,000 | 1 | 5,000 | ||||
| 2015-11-23 | 2015-11-20 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 1.1518 | -88,745 | -102 | 973,802 | ||||
| 2015-11-23 | 2015-11-19 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 1.3794 | -8,061 | -11 | 10,625,547 | ||||
| 2015-11-19 | 2015-11-19 | 4 | CARUSO JAMES V | CLRB | Common Stock, par value $0.00001 per share | D | 1.5000 | 2,000 | 3 | 4,000 | ||||
| 2015-11-19 | 2015-11-18 | 4 | CARUSO JAMES V | CLRB | Common Stock, par value $0.00001 per share | D | 1.3949 | 2,000 | 3 | 2,000 | ||||
| 2015-10-29 | 2015-10-28 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 2.0000 | -99 | -0 | 1,070,608 | ||||
| 2015-10-26 | 2015-10-23 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 2.0000 | -2,000 | -4 | 1,070,707 | ||||
| 2015-10-26 | 2015-10-22 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 2.0000 | -6,866 | -14 | 1,072,707 | ||||
| 2015-10-08 | 2015-10-06 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 2.0000 | -2,554 | -5 | 1,079,573 | ||||
| 2015-10-06 | 2015-10-05 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 2.1082 | -2,800 | -6 | 1,082,127 | ||||
| 2015-10-06 | 2015-10-02 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 2.0000 | -4,700 | -9 | 1,084,927 | ||||
| 2015-10-02 | 2015-10-01 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 2.0599 | -21,600 | -44 | 1,089,627 | ||||
| 2015-10-02 | 2015-09-30 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 2.0000 | -6,340 | -13 | 1,111,227 | ||||
| 2015-09-30 | 2015-09-29 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 2.1500 | -1,701 | -4 | 1,117,567 | ||||
| 2015-09-30 | 2015-09-28 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 2.6500 | -10,000 | -26 | 1,119,268 | ||||
| 2015-09-30 | 2015-09-28 | 4 | AWM Investment Company, Inc. By Limited Partnerships | CLRB | Common Stock | I | 2.1699 | -13,100 | -28 | 1,129,268 | ||||
| 2015-06-10 | 2015-06-09 | 4 | BERNS PAUL L | CLRB | Stock Option (right to buy) | D | 2.64 | 5,000 | 5,000 | |||||
| 2015-06-10 | 2015-06-09 | 4 | NEIS JOHN | CLRB | Stock Option (right to buy) | D | 2.64 | 5,000 | 5,000 | |||||
| 2015-06-10 | 2015-06-09 | 4 | HILL STEPHEN A | CLRB | Stock option (right to buy) | D | 2.64 | 5,000 | 5,000 | |||||
| 2015-03-04 | 2015-02-26 | 4 | HILL STEPHEN A | CLRB | Stock option (right to buy) | D | 2.69 | 5,500 | 5,500 | |||||
| 2015-03-04 | 2015-02-26 | 4 | BERNS PAUL L | CLRB | Stock Option (right to buy) | D | 2.69 | 5,000 | 5,000 | |||||
| 2015-03-04 | 2015-02-26 | 4 | NEIS JOHN | CLRB | Stock Option (right to buy) | D | 2.69 | 5,000 | 5,000 | |||||
| 2015-03-04 | 2015-02-26 | 4 | Genn John Patrick | CLRB | Stock option (right to buy) | D | 2.69 | 10,000 | 10,000 | |||||
| 2014-12-18 | 2014-11-24 | 4 | Szakacs Cameron | CLRB | Employee Stock Option (right to buy) | D | 2.74 | 50,000 | 50,000 | |||||
| 2014-09-10 | 2014-09-08 | 4 | MARXE AUSTIN W & GREENHOUSE DAVID M By Limited Partnerships | CLRB | Common Stock | I | 3.0000 | 182 | 1 | 1,142,368 | ||||
| 2014-09-09 | 2014-09-08 | 4 | Genn John Patrick | CLRB | Stock purchase warrant (right to buy) | D | 4.68 | 0.0100 | 10,000 | 0 | 77,083 | |||
| 2014-09-09 | 2014-08-29 | 4 | Genn John Patrick | CLRB | Stock purchase warrant (right to buy) | D | 4.68 | 0.0100 | 15,000 | 0 | 67,083 | |||
| 2014-09-09 | 2014-08-28 | 4 | Genn John Patrick | CLRB | Stock purchase warrant (right to buy) | D | 4.68 | 0.0100 | 22,000 | 0 | 52,083 | |||
| 2014-09-09 | 2014-08-27 | 4 | Genn John Patrick | CLRB | Stock purchase warrant (right to buy) | D | 4.68 | 0.0100 | 3,000 | 0 | 30,083 | |||
| 2014-09-08 | 3 | MARXE AUSTIN W & GREENHOUSE DAVID M By Limited Partnerships | CLRB | Common Stock | I | 2,132,000 | ||||||||
| 2014-09-08 | 3 | MARXE AUSTIN W & GREENHOUSE DAVID M By Limited Partnerships | CLRB | Common Stock | I | 2,132,000 | ||||||||
| 2014-09-08 | 2014-08-22 | 4 | MARXE AUSTIN W & GREENHOUSE DAVID M By Limited Partnerships | CLRB | Common Stock | I | 3.0000 | 5,699 | 17 | 1,142,186 | ||||
| 2014-09-08 | 2014-08-19 | 4 | MARXE AUSTIN W & GREENHOUSE DAVID M By Limited Partnerships | CLRB | Common Stock | I | 3.0500 | 65,687 | 200 | 1,136,487 | ||||
| 2014-09-08 | 2014-08-18 | 4 | MARXE AUSTIN W & GREENHOUSE DAVID M By Limited Partnerships | CLRB | Common Stock | I | 3.0500 | 4,800 | 15 | 1,070,800 | ||||
| 2014-09-05 | 3 | Cormorant Global Healthcare Master Fund, LP | CLRB | Common Stock | I | 1,060,000 | ||||||||
| 2014-09-05 | 3 | Cormorant Global Healthcare Master Fund, LP | CLRB | Common Stock | I | 1,060,000 | ||||||||
| 2014-09-05 | 3 | Cormorant Global Healthcare Master Fund, LP | CLRB | Common Stock | I | 1,060,000 | ||||||||
| 2014-09-05 | 3 | Cormorant Global Healthcare Master Fund, LP | CLRB | Common Stock | I | 1,060,000 | ||||||||
| 2014-09-05 | 3 | Cormorant Global Healthcare Master Fund, LP | CLRB | Common Stock | I | 1,060,000 | ||||||||
| 2014-08-22 | 3/A | NEIS JOHN See Foonote | CLRB | Common Stock, par value $0.00001 per share | I | 363,715 | ||||||||
| 2014-08-22 | 2014-08-20 | 4 | HILL STEPHEN A | CLRB | Stock purchase warrant (right to buy) | D | 4.68 | 0.0100 | 5,300 | 0 | 21,351 | |||
| 2014-08-22 | 2014-08-20 | 4 | HILL STEPHEN A | CLRB | Common Stock, par value $0.00001 per share | D | 3.7500 | 5,300 | 20 | 5,300 | ||||
| 2014-08-22 | 2014-08-20 | 4 | NEIS JOHN See Foonote | CLRB | Stock Purchase Warrant (right to buy) | I | 4.68 | 0.0100 | 138,711 | 1 | 268,711 | |||
| 2014-08-22 | 2014-08-20 | 4 | NEIS JOHN See Foonote | CLRB | Convertible Debenture (right to buy) | I | 10.00 | 3.7500 | -50,000 | -188 | 0 | |||
| 2014-08-22 | 2014-08-20 | 4 | NEIS JOHN See Foonote | CLRB | Stock Purchase Warrant (right to buy) | I | 4.68 | 0.0100 | 130,000 | 1 | 130,000 | |||
| 2014-08-22 | 2014-08-20 | 4 | NEIS JOHN See Foonote | CLRB | Common Stock, par value $0.00001 per share | I | 3.7500 | 138,711 | 520 | 632,426 | ||||
| 2014-08-22 | 2014-08-20 | 4 | NEIS JOHN See Foonote | CLRB | Common Stock, par value $0.00001 per share | I | 3.7500 | 130,000 | 488 | 493,715 | ||||
| 2014-08-22 | 2014-08-20 | 4 | Pedder Simon | CLRB | Stock purchase warrant (right to buy) | D | 4.68 | 0.0100 | 13,300 | 0 | 277,578 | |||
| 2014-08-22 | 2014-08-20 | 4 | Pedder Simon | CLRB | Common Stock, par value $0.00001 per share | D | 3.7500 | 13,300 | 50 | 13,300 | ||||
| 2014-08-18 | 3 | Genn John Patrick | CLRB | Common Stock, par value $0.00001 per share | D | 7,064 | ||||||||
| 2014-08-18 | 3 | Genn John Patrick | CLRB | Common Stock, par value $0.00001 per share | D | 7,064 | ||||||||
| 2014-08-18 | 3 | Weichert Jamey P | CLRB | Common Stock, par value $0.00001 per share | D | 470,672 | ||||||||
| 2014-08-18 | 3 | Weichert Jamey P | CLRB | Common Stock, par value $0.00001 per share | D | 470,672 |
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
